COVID-19 Testing: A Tale of Two Nations

This chapter contrasts the UK's effective COVID-19 testing system with the struggles faced in the U.S., focusing on the UK's proactive investment and distribution initiatives. It discusses the FDA's cautious approval process for rapid tests in the U.S., highlighting regulatory challenges and economic pressures that impact test availability. The conversation emphasizes the urgent need for accessible rapid testing solutions in the U.S., especially as demand surges during critical periods.